2019 top news stories
Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first patient in gene-editing therapy trial.…

Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first patient in gene-editing therapy trial.…
Voyager Therapeutics will develop and commercialise Neurocrine Biosciences' gene therapy candidates used to treat severe neurological conditions after a collaboration was…
PeptiDream has entered an agreement with Shionogi for identifying and developing a series of blood-brain barrier (BBB) penetrating peptide drug…
Ferring Pharmaceuticals (US) has entered an exclusive agreement with Sun Pharmaceutical Industries to acquire the commercialisation rights for a generic…
Keros Therapeutics has raised $23m in series B funding round.
Antengene Corporation has raised $120m in a series B funding round led by Boyu Capital and FountainVest.
DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics.
Moderna has priced its initial public offering (IPO) of 26 million common stock shares priced at $23 a share to…
Thank you for subscribing to Clinical Trials Arena